RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Bruker
B

Bruker portfolio

Bruker has 1 portfolio company on record at Recent Funding.

Website: bruker.com.
Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $100M.
Latest deal: Mercy BioAnalytics · Sep 3, 2025.
About this page

Its most recent investment on record is Mercy BioAnalytics's $59M Series B+ round in September 2025, alongside BrightEdge - American Cancer Society, Mindshift Capital, Sozo Ventures and 6 others. That company is in Health and bio. It has co-invested with BrightEdge - American Cancer Society, Sozo Ventures and Novalis LifeSciences, most often BrightEdge - American Cancer Society (2 rounds).

What Bruker invests in

How Bruker invests

StageDealsCapital in rounds
Series B+ 1 50%$59M
Series A 1 50%$41M
YearDealsCapital in rounds
2023 1 50%$41M
2025 1 50%$59M

Bruker portfolio companies

CompanyRound with BrukerTotal raisedLatest raise
MMercy BioAnalytics
Health and bio
Series B+ · $59M$100MSep 3, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Bruker. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Bruker, which is a subset of its real portfolio. API: /api/v1/investors/bruker (get a free API key). More: the most active VC firms and new venture capital funds.